Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human PGP9.5 Protein (Fc Tag) (AC1021)
Cat.#: ACPP-1021
Specifications
Despition Recombinant Human PGP9.5 Protein (Fc Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence hFc (Glu99-Ala330) + UCHL1 (Met1-Cys220) Molecular Weight 46.3 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag N-terminal Human Fc Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1154 Recombinant Human FGF19 Protein (6×His Tag) (AC1154) 50 µg inquiry ACPP-1826 Human CRYGN Protein (AC1826) 5 µg inquiry ACPP-1047 Recombinant Human Myelin Basic Protein Protein (Fc Tag) (AC1047) 50 µg inquiry ACPP-1363 Presenilin 1 Blocking Peptide (AC1363) 250 µg inquiry ACPP-1006 Recombinant Human TNF Receptor II Protein (6×His Tag) (AC1006) 50 µg inquiry ACPP-1171 Recombinant Human KCNK9 Protein (Fc Tag) (AC1171) 50 µg inquiry ACPP-1819 Human TRH Protein (AC1819) 100 mg inquiry ACPP-1032 Recombinant Human PGRPS Protein (6×His Tag) (AC1032) 50 µg inquiry ACPP-1566 Human STMN1 Protein (AC1566) 5 µg inquiry ACPP-1801 Human TEN1 Protein (AC1801) 2 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket